MetaCap

20/20 Biolabs Statistics

NASDAQ: AIDXHealth CarePrecision InstrumentsUSD

0.1571-0.0245 (-13.49%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

20/20 Biolabs by the numbers

20/20 Biolabs has a market capitalization of $2.2 million based on 13.99M shares outstanding. With trailing EPS of $-0.75, 20/20 Biolabs is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 49.4% below its 50-day average and 87.6% below its 200-day average.

Average daily trading volume is 139.24K shares, or about $21,875 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

Valuation

Price / sales (latest FY)
1.07
EPS (TTM)
$-0.75

Price and trading

Previous close
0.1816
Open
0.1802
Day range
0.1556 – 0.1803
52-week range
0.1556 – 50.00
Beta
—
Volume
301.48K

Dividends and events

Additional statistics

Market Cap
2.20M
Eps
-0.75
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
50.00
Week52 Low
0.16
Avg Volume
139.24K
Shares Outstanding
13.99M
Ma50
0.31
Ma200
1.27
Pct From52w High
-99.69%
Pct From52w Low
0.96%

Related